BUSINESS

• Macrocyclic Peptide Hits Milestone in Joint R&D: PeptiDream/Bayer
  April 6, 2023

• Avastin Biosimilar Grabs Ovarian Cancer Nod: Nippon Kayaku/Celltrion
  April 6, 2023

• Sumitomo to Combine US Subsidiaries as It Looks towards Post-Latuda Era
  April 5, 2023

• Lecanemab Use at MCI Stage Might Have Larger Impact on Delaying AD Progression: Eisai
  April 5, 2023

• Padcev/Keytruda Combo Wins US Accelerated Nod for First-Line Bladder Cancer: Astellas
  April 5, 2023

• Xocova Nabs Fast-Track Tag in US: Shionogi
  April 5, 2023

• Silgard 9 Now Available under NIP; MSD Renews Call for Cervical Cancer Prevention
  April 4, 2023

• Insmed Taps Ex-Gilead Director Makoto Nakamura as New Japan Chief
  April 4, 2023

• Yoshihiro Toyohara to Lead Teva Takeda from June
  April 4, 2023

• Eisai to Offer Tazverik for NCC’s Patient-Proposed Study
  April 4, 2023

• 19 of 41 Drug Makers Log P/B Ratio Below 1; TSE’s Quest to Boost Market Cap Not Easy
  April 4, 2023

• 5 Otsuka Execs Earn 100 Million-Plus Pay in 2022: Securities Filing
  April 4, 2023

• Chugai’s Annual Pay Tops 12 Million Yen for 1st Time: Securities Report
  April 4, 2023

• Sanofi Seeks Dupixent Label Expansion into CSU in Japan
  April 3, 2023

• Novartis Takes Over Radioligand Therapy Lutathera from Fujifilm in Japan
  April 3, 2023

• Shionogi’s Xocova Now Available through Normal Commercial Channel
  April 3, 2023

• Entyvio Hits Primary Goal in Pouchitis Study: Takeda
  April 3, 2023

• Ultragenyx Plans Japan Submission of Evinacumab in May: CEO
  March 31, 2023

• Takeda’s Iwasaki to Retire as Representative Director
  March 31, 2023

• Pfizer Japan Files 20-Valent Pneumococcal Vaccine for Pediatric Use
  March 31, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 141
• 142
• 143
• 144
• 145
• 146
• 147
• 148
• 149
• …
• Next ›
• 最終 »